Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Joseph A. Sparano

Weiler Division

Montefiore-Einstein Cancer Center

Albert Einstein College of Medicine

Montefiore Medical Center

USA

[email]@*.harvard.edu

Name/email consistency: high

[Claim this account]

Affiliations

Weiler Division, Montefiore-Einstein Cancer Center, Albert Einstein College of Medicine, Montefiore Medical Center, USA. 2012
Albert Einstein Cancer Center, Montefiore Medical Center, Bronx, NY 10467, USA. 1996 - 2004
Eastern Cooperative Oncology Group, Philadelphia, Pennsylvania, USA. 2004
Department of Oncology, Albert Einstein Cancer Center, Montefiore Medical Center, Albert Einstein College of Medicine, USA. 1996 - 2001
Eastern Cooperative Oncology Group Breast Cancer Committee, Albert Einstein Comprehensive Cancer Center, Montefiore Medical Center, Bronx, USA. 1999

References

TOP2A RNA expression and recurrence in estrogen receptor-positive breast cancer. Sparano, J.A., Goldstein, L.J., Davidson, N.E., Sledge, G.W., Gray, R. Breast Cancer Res. Treat. (2012) [Pubmed]
Evaluating antiangiogenesis agents in the clinic: the Eastern Cooperative Oncology Group Portfolio of Clinical Trials. Sparano, J.A., Gray, R., Giantonio, B., O'Dwyer, P., Comis, R.L. Clin. Cancer Res. (2004) [Pubmed]
Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196. Sparano, J.A., Bernardo, P., Stephenson, P., Gradishar, W.J., Ingle, J.N., Zucker, S., Davidson, N.E. J. Clin. Oncol. (2004) [Pubmed]
Phase 2 trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with poor-prognosis, intermediate-grade non-Hodgkin lymphoma: an Eastern Cooperative Oncology Group trial (E3493). Sparano, J.A., Weller, E., Nazeer, T., Habermann, T., Traynor, A.E., Manalo, J., Cassileth, P. Blood (2002) [Pubmed]
Clinical aspects and management of AIDS-related lymphoma. Sparano, J.A. Eur. J. Cancer (2001) [Pubmed]
Taxanes for breast cancer: an evidence-based review of randomized phase II and phase III trials. Sparano, J.A. Clin. Breast Cancer (2000) [Pubmed]
Phase I trial of escalating doses of paclitaxel plus doxorubicin and dexrazoxane in patients with advanced breast cancer. Sparano, J.A., Speyer, J., Gradishar, W.J., Liebes, L., Sridhara, R., Mendoza, S., Fry, D., Egorin, M.J. J. Clin. Oncol. (1999) [Pubmed]
Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study. Sparano, J.A., Neuberg, D., Glick, J.H., Robert, N.J., Goldstein, L.J., Sledge, G.W., Wood, W. J. Clin. Oncol. (1997) [Pubmed]
Phase I trial of high-dose mitoxantrone plus cyclophosphamide and filgrastim in patients with advanced breast carcinoma. Sparano, J.A., Robert, N., Silverman, P., Lazarus, H., Malik, U., Venkatraj, U., Sarta, C. J. Clin. Oncol. (1996) [Pubmed]
Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma. Sparano, J.A., Wiernik, P.H., Hu, X., Sarta, C., Schwartz, E.L., Soeiro, R., Henry, D.H., Mason, B., Ratech, H., Dutcher, J.P. J. Clin. Oncol. (1996) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.